⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20816104 | 0.84 | — | — | |
| SCHEMBL8815053 | 0.84 | — | — | |
| SCHEMBL4554895 | 0.79 | TSHR (0.31) | — | |
| SCHEMBL15751967 | 0.73 | MAPT (0.43) | — | |
| SCHEMBL14678290 | 0.71 | — | — | |
| SCHEMBL3912744 | 0.71 | — | — | |
| SCHEMBL3367644 | 0.70 | — | — | |
| SCHEMBL20548163 | 0.70 | SMN1; SMN2 (0.39) | — | |
| SCHEMBL5828254 | 0.70 | FOLH1 (0.34) | — | |
| SCHEMBL6395056 | 0.70 | FOLH1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1614 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3027776-B1 | METHODS AND MOLECULAR PHARMACODYNAMIC BIOMARKERS FOR MULTIPLE SIGNALING PATHWAYS IN RESPONSE TO CARBOXYAMIDOTRIAZOLE OROTATE | TACTICAL THERAPEUTICS INC (US) | 2024-02-07 | — | — | EP | claimed |
| US-20230056203-A1 | METHODS AND COMPOSITIONS FOR TARGETING CANCER CELLS IN METASTASES | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-02-23 | — | — | US | claimed |
| EP-3268744-B1 | PD-ECGF AS BIOMARKER OF CANCER | FUNDACIO INST DINVESTIGACIO BIOMEDICA DE BELLVITGE IDIBELL (ES) | 2021-08-11 | — | — | EP | claimed |
| EP-3191114-B1 | OCCIDIOFUNGIN FORMULATIONS AND USES THEREOF | UNIV MISSISSIPPI STATE (US) | 2021-03-03 | — | — | EP | claimed |
| EP-3102244-B1 | ANTIBODY-DRUG CONJUGATES AND IMMUNOTOXINS | ONCOMATRYX BIOPHARMA S L (ES) | 2020-03-18 | — | — | EP | claimed |
| US-10385139-B2 | Murine, chimeric, humanized or human anti-TNF-alpha antibodies | IBC PHARMACEUTICALS, INC. (US) | 2019-08-20 | — | — | US | claimed |
| EP-2805945-B1 | Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors | MSD ITALIA SRL (IT) | 2019-04-03 | — | — | EP | claimed |
| EP-2504035-B1 | COMPOSITIONS AND METHODS FOR INHIBITING CELLULAR ADHESION OR DIRECTING DIAGNOSTIC OR THERAPEUTIC AGENTS TO RGD BINDING SITES | ALLEGRO PHARMACEUTICALS INC (US) | 2019-03-27 | — | — | EP | claimed |
| EP-3102606-B1 | ANTIBODY-DRUG CONJUGATES AND IMMUNOTOXINS | ONCOMATRYX BIOPHARMA S L (ES) | 2018-09-12 | — | — | EP | claimed |
| US-10022427-B2 | Interferon lambda-antibody complexes | IBC PHARMACEUTICALS, INC. (US) | 2018-07-17 | — | — | US | claimed |
| US-20010038826-A1 | Formulation and method for treating neoplasms by inhalation | ZIVENA, INC. | 2001-11-08 | — | — | US | claimed |
| US-20010038827-A1 | Formulation and method for treating neoplasms by inhalation | ZIVENA, INC. | 2001-11-08 | — | — | US | claimed |
| US-20010036444-A1 | Formulation and method for treating neoplasms by inhalation | ZIVENA, INC. | 2001-11-01 | — | — | US | claimed |
| WO-2001052868-A1 | COMBINATIONS FOR TREATING NEOPLASMS | YU BAOFA (US) | 2001-07-26 | — | — | WO | claimed |
| EP-0954283-A2 | FORMULATION AND METHOD FOR TREATING NEOPLASMS BY INHALATION | BATTELLE MEMORIAL INSTITUTE (US) | 1999-11-10 | — | — | EP | claimed |
| EP-0750637-B1 | DNA ENCODING CAI RESISTANCE PROTEINS AND USES THEREOF | US HEALTH (US) | 1998-12-30 | — | — | EP | claimed |
| WO-1998029110-A2 | FORMULATION AND METHOD FOR TREATING NEOPLASMS BY INHALATION | BATTELLE MEMORIAL INSTITUTE (US) | 1998-07-09 | — | — | WO | claimed |
| US-5652223-A | DNA encoding CAI resistance proteins and uses thereof | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-07-29 | — | — | US | claimed |
| EP-0750637-A1 | DNA ENCODING CAI RESISTANCE PROTEINS AND USES THEREOF | THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services (US) | 1997-01-02 | — | — | EP | claimed |
| WO-1995025125-A1 | DNA ENCODING CAI RESISTANCE PROTEINS AND USES THEREOF | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-09-21 | — | — | WO | claimed |